Viatris spokeswoman Jennifer Mauer issued a statement that “the decision to cease operations at Chestnut Ridge as part of a global, multi-site restructuring initiative was one we did not take lightly and in no way reflects upon the company’s appreciation for the commitment, work ethic and valuable contributions of our employees.”
She added the company's intent has been to provide “generous comprehensive severance packages” for those being let go. Viatris formed in 2020 and sought incorporation in Delaware, with global centers in Pittsburgh and Hyderabad, India, and Shanghai, China
Some industry groups have lobbied for enhancing the U.S. pharmaceutical supply chain. The Association for Accessible Medicine in April 2020 proposed a blueprint for the federal government to establish a list of essential medicines for the U.S. and expand domestic production.
But the loss of the Morgantown plant won't have a major impact on domestic production of generic medicine, said Rachel Schwartz, a spokeswoman for the Association for Accessible Medicine.
Our Revolution's letter to Biden said the Morgantown workers include union members, researchers and scientists “who together can produce more than 18 billion doses of life-saving generic drugs each year.” But Schwartz said nearly 150 manufacturing sites remain nationwide, together producing more than 60 billion of generic medicine doses annually.